Biotech & MedTech News
-
President & CEO Letter to Shareholders
March 12, 2020 (Source) – Dear Nova Leap Shareholders: As Nova Leap enters its 5th year of existence, this…
-
Nova Leap Health Corp. Reports Fourth Quarter and Full Year 2019 Financial Results
March 12, 2020 (Source) – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 TSX…
-
Nova Leap Health Corp to Present at the Spring Investor Summit on March 25th-26th in New York City
March 4, 2020 (Source) – Nova Leap Health Corp (NLH), a 2019 TSX Venture 50™ ranked company focused on…
-
President & CEO of Nova Leap Health Corp. to Discuss Record 2019 Results at the 2020 Spring Investor Summit in NYC
February 18, 2020 (Source) – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 TSX…
-
Izotropic Corporation Receives Notice of Allowance from US Patent Office
February 5, 2020 (Source) – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (CNSX:IZO.CN) (OTC:IZOZF) (FRA:1R3) Izotropic Corporation is pleased to announce that…
-
StageZero Life Sciences to participate in Mercer’s new vendor database in the U.S.
January 30, 2020 (Source) – StageZero Life Sciences, Ltd (TSX:SZLS) (“StageZero” or the “Company”) today announced that it is…
-
StageZero Life Sciences Announces Closing of Financing
January 27, 2020 (Source) – StageZero Life Sciences, Ltd (TSX:SZLS) (“StageZero” or the “Company”) today announced that it closed…
-
Nova Leap Health Corp. Closes Second and Final Tranche of Oversubscribed Non-Brokered Private Placement
January 17, 2020 (Source) – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or the “Company”), a 2019 TSX…
-
Nova Leap Health Corp. Announces Further Oversubscription of Non-Brokered Private Placement of Convertible Debentures and Increase in Offering
January 14, 2020 (Source) – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or the “Company”), a 2019 TSX…
-
StageZero Life Sciences Retains Fig House Communications to Manage Investor Relations Activities
January 13, 2020 (Source) – StageZero Life Sciences, Ltd (TSX:SZLS) (“StageZero” or the “Company”) today announced that it has…